Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line. [electronic resource]
- Biochemical pharmacology Jul 1995
- 391-8 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
0006-2952
10.1016/0006-2952(95)00135-m doi
Cell Division--drug effects Cell-Free System Dose-Response Relationship, Drug Drug Resistance Folic Acid Antagonists--pharmacology Glutamates--pharmacology Guanine--analogs & derivatives Humans Methotrexate--pharmacology Pemetrexed Peptide Synthases--antagonists & inhibitors Pteroylpolyglutamic Acids--metabolism Quinazolines--pharmacology Thiophenes--pharmacology Thymidylate Synthase--antagonists & inhibitors Time Factors Tumor Cells, Cultured--drug effects